CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice

The antagonism of CXC-chemokine receptor 4 (CXCR4) with AMD3100 improves cardiac performance after myocardial infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow to the regenerating vasculature. We investigated whether AMD3100 may accelerate diabetes-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nishimura, Yukihide, Ii, Masaaki, Qin, Gangjian, Hamada, Hiromichi, Asai, Jun, Takenaka, Hideya, Sekiguchi, Haruki, Renault, Marie-Ange, Jujo, Kentaro, Katoh, Norito, Kishimoto, Saburo, Ito, Aiko, Kamide, Christine, Kenny, John, Millay, Meredith, Misener, Sol, Thorne, Tina, Losordo, Douglas W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276738/
https://ncbi.nlm.nih.gov/pubmed/22048734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2011.356
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak